摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[(3R,5S)-7-chloro-1-(3-hydroxy-2-hydroxymethyl-2-methylpropyl)-5-(2,3-dimethoxyphenyl)-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepine-3-acetyl]-4-hydroxypiperidine-4-acetic acid methyl ester | 189060-16-0

中文名称
——
中文别名
——
英文名称
N-[(3R,5S)-7-chloro-1-(3-hydroxy-2-hydroxymethyl-2-methylpropyl)-5-(2,3-dimethoxyphenyl)-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepine-3-acetyl]-4-hydroxypiperidine-4-acetic acid methyl ester
英文别名
methyl 2-[1-[2-[(3R,5S)-7-chloro-5-(2,3-dimethoxyphenyl)-1-[3-hydroxy-2-(hydroxymethyl)-2-methylpropyl]-2-oxo-5H-4,1-benzoxazepin-3-yl]acetyl]-4-hydroxypiperidin-4-yl]acetate
N-[(3R,5S)-7-chloro-1-(3-hydroxy-2-hydroxymethyl-2-methylpropyl)-5-(2,3-dimethoxyphenyl)-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepine-3-acetyl]-4-hydroxypiperidine-4-acetic acid methyl ester化学式
CAS
189060-16-0
化学式
C32H41ClN2O10
mdl
——
分子量
649.138
InChiKey
MBUJMHNPVDZGET-LEAFIULHSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    45
  • 可旋转键数:
    12
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.53
  • 拓扑面积:
    155
  • 氢给体数:
    3
  • 氢受体数:
    10

文献信息

  • Benzoxazepine compounds, their production and use
    申请人:Yukimasa Hidefumi
    公开号:US20070117787A1
    公开(公告)日:2007-05-24
    This invention provides new benzoxazepine compounds represented by the formula: [wherein R stands for a lower alkyl group optionally substituted with a hydroxyl group, X stands for an optionally substituted carbamoyl group or an optionally substituted heterocyclic group having a deprotonatable hydrogen atom, R 1 stands for a lower alkyl group and W stands for a halogen atom] having activities of lowering cholesterol-level and lowering triglyceride-level, and being useful for prophylaxis and therapy of hyperlipidemia.
    本发明提供了一种新的苯并噁唑化合物,其表示为以下式子:[其中R代表可选地取代羟基的低碳基,X代表可选地取代的基甲酰基或具有可去质子氢原子的可选地取代的杂环基,R1代表低碳基,W代表卤素原子],具有降低胆固醇平和降低甘油三酯平的活性,适用于预防和治疗高脂血症。
  • 5-(2,3-Dialkoxyphenyl)-4,1-benzoxazepin-2-ones as anti-hyperlipidemics
    申请人:Takeda Chemical Industries, Ltd.
    公开号:EP1097928A1
    公开(公告)日:2001-05-09
    This invention provides new benzoxazepine compounds represented by the formula: [wherein R stands for a lower alkyl group optionally substituted with a hydroxyl group, X stands for an optionally substituted carbamoyl group or an optionally substituted heterocyclic group having a deprotonatable hydrogen atom, R1 stands for a lower alkyl group and W stands for a halogen atom] having activities of lowering chlesterol-level and lowering trigluceride-level, and being useful for prophylaxis and therapy of hyperlipidemia.
    本发明提供了由式表示的新的苯并氧氮杂卓化合物: [其中 R 代表被羟基任选取代的低级烷基,X 代表任选取代的基甲酰基或具有可去质子氢原子的任选取代的杂环基,R1 代表低级烷基,W 代表卤素原子],具有降低胆固醇平和降低甘油三酯平的活性,可用于高脂血症的预防和治疗。
  • BENZOXAZEPINE COMPOUNDS, THEIR PRODUCTION AND USE AS LIPID LOWERING AGENTS
    申请人:Takeda Chemical Industries, Ltd.
    公开号:EP0862562B1
    公开(公告)日:2001-07-04
  • US6110909A
    申请人:——
    公开号:US6110909A
    公开(公告)日:2000-08-29
  • US6613761B1
    申请人:——
    公开号:US6613761B1
    公开(公告)日:2003-09-02
查看更多